ANGLE plc (AGL.L)
| Previous Close | 12.75 |
| Open | 12.60 |
| Bid | 12.00 x 0 |
| Ask | 13.00 x 0 |
| Day's Range | 12.16 - 12.60 |
| 52 Week Range | 9.07 - 37.40 |
| Volume | |
| Avg. Volume | 1,458,045 |
| Market Cap | 31.687M |
| Beta (5Y Monthly) | 0.12 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.09 |
| Earnings Date | Apr 15, 2024 - Apr 19, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 70.00 |
ACCESSWIREAngle PLC Announces Parsortix HER2 Assay Showcased at AACR 2024
PARSORTIX HER2 ASSAY SHOWCASED AT PRESTIGIOUS INTERNATIONAL CANCER CONFERENCE CTC HER2 assay being developed for HER2 targeted drugs and antibody drug conjugates presented at internationally renowned AACR Annual Meeting 2024 GUILDFORD, SURREY / ACCESSWIRE ...
GlobeNewswirePresenting on the Emerging Growth Conference 69 Day 1 on April 3 Register Now
MIAMI, April 02, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 69th Emerging Growth Conference on April 3 & 4, 2024. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting compani
- ACCESSWIRE
Angle PLC Announces Parsortix at European Breast Cancer Conference
PARSORTIX SYSTEM AND ASSAYS BEING SHOWCASED AT A LEADING EUROPEAN BREAST CANCER CONFERENCE ANGLE presenting two posters highlighting the utility of the Company's new Portrait+ CTC Staining Kit and Portrait HER2 assay GUILDFORD, SURREY / ACCESSWIRE ...
